Autophagic flux

Autophagic flux refers to the **dynamic rate at which cellular substrates are delivered to lysosomes for degradation through the autophagy pathway**[1][3][5][7]. It encompasses the entire progression of autophagy, from the formation of autophagosomes, their fusion with lysosomes, to the breakdown and recycling of cargo. Flux is a crucial indicator of autophagic activity and cell homeostasis; impaired autophagic flux is implicated in a range of diseases, including neurodegeneration, cancer, and cardiovascular disorders[3][5]. Flux is modulated by numerous signaling pathways (such as AMPK, mTOR), and measured in experimental systems with markers such as LC3-II and p62, or by monitoring substrate turnover with pharmacological inhibitors of lysosomal function[1][3]. While essential for cell health, **autophagic flux** itself is *not* a direct drug target[3][5]. "Autophagic flux" is a cellular activity or measurement, not a canonical protein, receptor, or direct drug target. Use caution: it is common to conflate the process ("autophagy") with specific molecular targets (such as ULK1, Beclin 1, or ATG proteins) that regulate it, but "autophagic flux" itself does not fit target databases that require a discrete protein, gene, or receptor[1][3][5].

Other names

autophagy fluxautophagic process activityautophagy throughput